Page last updated: 2024-08-21

isoxazoles and Myocardial Infarction

isoxazoles has been researched along with Myocardial Infarction in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	14 (63.64)	29.6817
2010's	8 (36.36)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali, A; Ashraf, M; Hu, H; Maienschein-Cline, M; Tang, Y; Wang, Y; Xuan, W	1
Correia, A; Ferreira, MPA; Gao, E; Hirvonen, J; Kinnunen, SM; Mäkilä, E; Ohukainen, P; Ruskoaho, H; Rysä, J; Salonen, J; Santos, HA; Serpi, R; Szabo, Z; Tölli, M; Välimäki, MJ	1
Chen, X; Gao, E; Guo, Y; Li, C; Li, Y; Liu, Y; Tao, L; Wang, H; Wang, S; Wang, W; Xia, Y; Xiong, Z; Xu, X; Yan, W; Zhang, F; Zhang, J; Zhang, L; Zhang, X; Zhao, H; Zhao, S	1
Bucala, R; Chen, Y; Du, X; Gandavadi, S; Hare, AA; Jorgensen, WL; Leng, L; Li, J; Ma, C; Tong, C; Wang, J; Xiong, H; Yan, X; Yeung, E; Young, LH	1
Burchfield, JS; Gillette, TG; Hill, JA; Kong, Y; Lanka, V; McCallister, C; Paul, AL; Rothermel, BA; Schneider, JW; Tan, W	1
Bauer, M; Dietl, W; Hallström, S; Jürgens, G; Podesser, BK; Trescher, K; Ullrich, R; Wick, N; Wolfsberger, M; Wolner, E	1
Abbate, A; Hoke, NN; Houser, JE; Ownby, ED; Salloum, FN; Seropian, IM; Van Tassell, BW; Varma, A	1
He, XH; Li, H; Song, XM; Wang, YL; Zhan, J; Zhang, ZZ	1
Aguilar, HR; Frantz, DE; Goetsch, SC; Russell, JL; Schneider, JW	1
Aguilar, HR; Coe, H; Frantz, DE; Goetsch, SC; Liu, N; Luo, X; Russell, JL; Schneider, JW; van Rooij, E	1
Flynn, DM; Hill, RJ; Knight, DR; Magee, WP; Oleynek, JJ; Smith, AH; Tracey, WR	1
Birnbaum, Y; Hu, ZY; Rosanio, S; Schwarz, ER; Tavackoli, S; Uretsky, BF; Ye, Y	1
Vanchieri, C	1
Epstein, RA	1
Epstein, J; Klasser, GD	1
Aldington, S; Beasley, R; Shirtcliffe, P; Weatherall, M	1
Bernatsky, S; Hudson, M; Suissa, S	1
Jugdutt, BI	1
Ashcroft, DM; Chen, LC	1
Abbate, A; Baldi, A; Biasucci, LM; Biondi-Zoccai, GG; Capogrossi, MC; Crea, F; Das, A; Kukreja, RC; Mellone, P; Ockaili, RA; Piro, M; Qureshi, IZ; Salloum, FN; Severino, A; Straino, S; Vetrovec, GW	1
Blum, D; Cunnington, M; Funk, MJ; Mander, A; Qizilbash, N; Webb, D; Weil, J	1

Reviews

3 review(s) available for isoxazoles and Myocardial Infarction

Article	Year
Nonsteroidal anti-inflammatory drugs: confusion, controversy and dental implications. Journal (Canadian Dental Association), 2005, Volume: 71, Issue:8 Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Humans; Isoxazoles; Lactones; Myocardial Infarction; Peptic Ulcer; Pyrazoles; Sulfonamides; Sulfones; Toothache	2005
Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis. The New Zealand medical journal, 2005, Nov-25, Volume: 118, Issue:1226 Topics: Cardiac Surgical Procedures; Cardiovascular Diseases; Cerebrovascular Disorders; Cyclooxygenase Inhibitors; Humans; Isoxazoles; Myocardial Infarction; Odds Ratio; Outcome and Process Assessment, Health Care; Pain, Postoperative; Risk Factors; Sulfonamides; Survival Analysis	2005
Risk of myocardial infarction associated with selective COX-2 inhibitors: meta-analysis of randomised controlled trials. Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Etoricoxib; Humans; Isoxazoles; Lactones; Models, Statistical; Myocardial Infarction; Naproxen; Odds Ratio; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Risk; Risk Factors; Sulfonamides; Sulfones	2007

Other Studies

19 other study(ies) available for isoxazoles and Myocardial Infarction

Article	Year
Cardiac Progenitors Induced from Human Induced Pluripotent Stem Cells with Cardiogenic Small Molecule Effectively Regenerate Infarcted Hearts and Attenuate Fibrosis. Shock (Augusta, Ga.), 2018, Volume: 50, Issue:6 Topics: Animals; Cell Differentiation; Disease Models, Animal; Fibrosis; Humans; Induced Pluripotent Stem Cells; Isoxazoles; Mice; Myocardial Infarction; Myocytes, Cardiac; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Stem Cell Transplantation; Thiophenes	2018
Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction. Scientific reports, 2018, 03-15, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; GATA4 Transcription Factor; Gene Expression Regulation; Homeobox Protein Nkx-2.5; Hypertension; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Phosphorylation; Protein Interaction Domains and Motifs; Rats, Sprague-Dawley; Reperfusion Injury; Small Molecule Libraries	2018
Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction. Cardiovascular research, 2018, 08-01, Volume: 114, Issue:10 Topics: 3T3-L1 Cells; Adiponectin; Animals; Apoptosis; Disease Models, Animal; Heart Ventricles; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Myocardial Infarction; Myocytes, Cardiac; Organelle Biogenesis; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2018
Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction. Circulation, 2013, Jul-16, Volume: 128, Issue:3 Topics: AMP-Activated Protein Kinases; Animals; Antigens, Differentiation, B-Lymphocyte; Cardiotonic Agents; Cells, Cultured; Glucose; Histocompatibility Antigens Class II; Intramolecular Oxidoreductases; Isoxazoles; Macrophage Migration-Inhibitory Factors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Recombinant Proteins; Signal Transduction	2013
Pharmacological priming of adipose-derived stem cells promotes myocardial repair. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2016, Volume: 64, Issue:1 Topics: Acetylation; Adipogenesis; Adipose Tissue; Animals; Animals, Newborn; Biomarkers; Chondrogenesis; Chromatin Assembly and Disassembly; Coculture Techniques; Female; Histone Acetyltransferases; Histone Deacetylases; Histones; Homeobox Protein Nkx-2.5; Isoxazoles; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Osteogenesis; Stem Cell Transplantation; Stem Cells; Wound Healing	2016
Improved myocardial protection in the failing heart by selective endothelin-A receptor blockade. The Journal of thoracic and cardiovascular surgery, 2009, Volume: 137, Issue:4 Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Endothelin A Receptor Antagonists; Heart; Heart Failure; Isoxazoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Sulfonamides	2009
Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion. Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:6 Topics: Acute Disease; Animals; Apoptosis; Coronary Stenosis; Coronary Vessels; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Echocardiography; Injections, Intraperitoneal; Isoxazoles; Ligation; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Ventricular Remodeling	2009
Protective effect of PNU-120596, a selective alpha7 nicotinic acetylcholine receptor-positive allosteric modulator, on myocardial ischemia-reperfusion injury in rats. Journal of cardiovascular pharmacology, 2012, Volume: 59, Issue:6 Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Bungarotoxins; Cytokines; Disease Models, Animal; Inflammation; Isoxazoles; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NF-kappa B; Nicotinic Agonists; Phenylurea Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic	2012
Targeting native adult heart progenitors with cardiogenic small molecules. ACS chemical biology, 2012, Jun-15, Volume: 7, Issue:6 Topics: Animals; Cells, Cultured; Gene Expression; Heart; Heart Ventricles; Isoxazoles; Male; Mice; Mice, Transgenic; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Pericardium; Receptors, Notch; Transcriptional Activation	2012
Regulated expression of pH sensing G Protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease. ACS chemical biology, 2012, Jun-15, Volume: 7, Issue:6 Topics: Animals; Calcium; Cell Line; Cells, Cultured; Isoxazoles; Mice; Myocardial Infarction; Myocytes, Cardiac; Pericardium; Receptors, G-Protein-Coupled; Receptors, Notch; Transcriptional Activation	2012
Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury. American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:6 Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; CHO Cells; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Humans; Iodine Radioisotopes; Isoxazoles; Myocardial Infarction; Myocardial Reperfusion Injury; Purines; Rabbits; Radioligand Assay; Receptor, Adenosine A3; Sertraline; Transfection	2003
Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovascular research, 2005, Feb-01, Volume: 65, Issue:2 Topics: Animals; Atorvastatin; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme System; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Intramolecular Oxidoreductases; Isoxazoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phospholipases A; Phospholipases A2; Phosphorylation; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Sulfonamides	2005
Could Bextra increase heart risks too? Health news (Waltham, Mass.), 2004, Volume: 10, Issue:12 Topics: Coronary Artery Bypass; Cyclooxygenase Inhibitors; Drug and Narcotic Control; Health Status; Humans; Isoxazoles; Myocardial Infarction; Stroke; Sulfonamides	2004
Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention. Journal of the National Cancer Institute, 2005, Apr-20, Volume: 97, Issue:8 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents; Celecoxib; Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Incidence; Isoxazoles; Lactones; Membrane Proteins; Meta-Analysis as Topic; Myocardial Infarction; Neoplasms; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; United States; United States Food and Drug Administration	2005
Regulatory paternalism in the market for drugs: lessons from Vioxx and Celebrex. Yale journal of health policy, law, and ethics, 2005,Summer, Volume: 5, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chromans; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug and Narcotic Control; Drug Industry; Humans; Hypoglycemic Agents; Isoxazoles; Lactones; Myocardial Infarction; Paternalism; Platelet Aggregation Inhibitors; Pyrazoles; Sulfonamides; Sulfones; Thiazolidinediones; Troglitazone; Truth Disclosure; United States; United States Food and Drug Administration; Vasodilator Agents	2005
Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis and rheumatism, 2006, Aug-15, Volume: 55, Issue:4 Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Case-Control Studies; Cohort Studies; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Myocardial Infarction; Random Allocation; Treatment Outcome	2006
Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction. Circulation, 2007, Jan-23, Volume: 115, Issue:3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cardiovascular Diseases; Celecoxib; Cyclooxygenase Inhibitors; Humans; Isoxazoles; Lactones; Myocardial Infarction; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Risk Factors; Sulfonamides; Sulfones; Ventricular Remodeling	2007
Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat. Journal of cardiovascular pharmacology, 2007, Volume: 50, Issue:5 Topics: Animals; Apoptosis; Arterioles; Cyclooxygenase 2 Inhibitors; Cytokines; Echocardiography; Heart; Isoxazoles; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Survival Analysis; Ventricular Remodeling	2007
Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis. Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:6 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cohort Studies; Cyclooxygenase 2 Inhibitors; Databases, Factual; Female; Follow-Up Studies; Humans; Isoxazoles; Lactones; Male; Middle Aged; Myocardial Infarction; Naproxen; Osteoarthritis; Proportional Hazards Models; Pyrazoles; Retrospective Studies; Risk Factors; Stroke; Sulfonamides; Sulfones; United States	2008